News

St. Jude Medical, Inc., a global medical device company, announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite® and QuickFlex® Left-Ventricular (LV) Leads, used...

First landmark CIED replacement study of all companies’ cardiac devices provides insight into infection outcomes and prevention The BIOTRONIK sponsored REPLACE study(1,2) is the first prospective, multicenter trial to examine a broad range...

First study of its kind using multiple temperature-controlled radiofrequency devices to assess the safety and effectiveness of surgical ablation in treating non-paroxysmal atrial fibrillation Estech, a leader in minimally invasive and...

Rollout of novel oral anticoagulants poised to drastically change the clinical practice landscape The U.S. anticoagulant market is on the verge of a major shift in clinical practice. It is transitioning from a market dominated by a single...

Prospective Studies of Patients at High Risk for Cardiac Device Infections TYRX®, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections (SSIs) associated with...

Data Selected for Moderated Poster Presentation at American College of Cardiology 61st Annual Scientific Session & Expo Gencaro Potentially the First Genetically-Targeted Treatment for Prevention of Atrial Fibrillation ARCA biopharma,...

Lasorda will help educate all Americans and their physicians that you can restore heart health and maintain an active lifestyle with a BIOTRONIK pacemaker; first Pilot Program announced for March 28th in Phoenix BIOTRONIK, a leading...

Poster Presented at American College of Cardiology Annual Scientific Session Highlights Impact of Convergent Procedure on Left Atrial Size and Left Ventricular Ejection Fraction Data presented by Toplisek et al at the American College of...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that that more than 60,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest® Wearable...

Study Results Presented in Poster Presentation at the American College of Cardiology 61st Annual Scientific Sessions AliveCor, the developer of a breakthrough mobile electrocardiogram (ECG) recorder, announced results from a study that...